Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5189)
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,906
Price
$425.55
Total Value
$811.10K
Shares Held After
46,574
% of Holdings
3.9%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
3,321
Price
$20.88
Total Value
$69.34K
Shares Held After
71,322
% of Holdings
4.4%
Syndax Pharmaceuticals Inc (SNDX)
Podlesak Dennis — Director
Shares
8,000
Price
$14.21
Total Value
$113.72K
Shares Held After
239,763
% of Holdings
3.2%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP&CFO
Shares
2,850
Price
$72.87
Total Value
$207.68K
Shares Held After
166,143
% of Holdings
1.7%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$32.07
Total Value
$240.53K
Shares Held After
32,316
% of Holdings
18.8%
ANGIODYNAMICS INC (ANGO)
Trowbridge Stephen A — EVP and CFO
Shares
23,615
Price
$12.27
Total Value
$289.76K
Shares Held After
280,461
% of Holdings
7.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$599.30
Total Value
$23.97K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
919
Price
$597.66
Total Value
$549.25K
Shares Held After
324,483
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,355
Price
$596.86
Total Value
$808.75K
Shares Held After
325,402
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,678
Price
$595.88
Total Value
$999.89K
Shares Held After
326,757
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,248
Price
$594.89
Total Value
$742.43K
Shares Held After
328,435
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,540
Price
$593.88
Total Value
$914.57K
Shares Held After
329,683
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,563
Price
$592.97
Total Value
$926.81K
Shares Held After
331,223
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,104
Price
$591.90
Total Value
$653.46K
Shares Held After
332,786
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
53
Price
$590.43
Total Value
$31.29K
Shares Held After
333,890
% of Holdings
0.0%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
1,044,990
Price
$0.02
Total Value
$17.76K
Shares Held After
95,481,309
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$28.27
Total Value
$335.88K
Shares Held After
377,802
% of Holdings
3.0%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Mahboob Vaseem — Chief Financial Officer
Shares
4,788
Price
$30.60
Total Value
$146.50K
Shares Held After
60,609
% of Holdings
7.3%
UTAH MEDICAL PRODUCTS INC (UTMD)
CORNWELL KEVIN L — Director
Shares
1,000
Price
$66.75
Total Value
$66.75K
Shares Held After
189,472
% of Holdings
0.5%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
865
Price
$426.87
Total Value
$369.25K
Shares Held After
48,480
% of Holdings
1.8%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
313
Price
$425.32
Total Value
$133.13K
Shares Held After
49,345
% of Holdings
0.6%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
6,933
Price
$21.00
Total Value
$145.59K
Shares Held After
25,267
% of Holdings
27.4%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
3,772
Price
$21.00
Total Value
$79.21K
Shares Held After
14,924
% of Holdings
25.3%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
6,395
Price
$21.00
Total Value
$134.29K
Shares Held After
17,990
% of Holdings
35.5%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
952,380
Price
$21.00
Total Value
$20.00M
Shares Held After
2,815,707
% of Holdings
33.8%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
2,667
Price
$118.00
Total Value
$314.71K
Shares Held After
146,501
% of Holdings
1.8%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
8,333
Price
$118.00
Total Value
$983.29K
Shares Held After
0
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$36.59
Total Value
$7.32M
Shares Held After
1,199,154
% of Holdings
14.3%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
6,606
Price
$28.50
Total Value
$188.27K
Shares Held After
234,192
% of Holdings
2.7%
THERMO FISHER SCIENTIFIC INC. (TMO)
Britt Lisa P. — Sr. VP and Chief HR Officer
Shares
2,831
Price
$706.45
Total Value
$2.00M
Shares Held After
11,560
% of Holdings
19.7%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
5,341
Price
$36.62
Total Value
$195.58K
Shares Held After
38,853
% of Holdings
12.1%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
1,237
Price
$35.58
Total Value
$44.01K
Shares Held After
44,194
% of Holdings
2.7%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,469
Price
$18.62
Total Value
$27.35K
Shares Held After
103,665
% of Holdings
1.4%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,252
Price
$18.62
Total Value
$41.93K
Shares Held After
396,878
% of Holdings
0.6%
ANGIODYNAMICS INC (ANGO)
Trowbridge Stephen A — EVP and CFO
Shares
1,720
Price
$12.17
Total Value
$20.93K
Shares Held After
304,076
% of Holdings
0.6%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
753
Price
$18.62
Total Value
$14.02K
Shares Held After
222,904
% of Holdings
0.3%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
312,000
Price
$0.02
Total Value
$5.77K
Shares Held After
94,436,319
% of Holdings
0.3%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,198
Price
$426.34
Total Value
$510.76K
Shares Held After
49,658
% of Holdings
2.4%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
968
Price
$426.34
Total Value
$412.70K
Shares Held After
168,221
% of Holdings
0.6%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
898
Price
$426.34
Total Value
$382.85K
Shares Held After
195,578
% of Holdings
0.5%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
3,430
Price
$426.34
Total Value
$1.46M
Shares Held After
91,232
% of Holdings
3.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
187
Price
$426.34
Total Value
$79.73K
Shares Held After
217,686
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,162
Price
$426.34
Total Value
$495.41K
Shares Held After
104,742
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
200
Price
$28.90
Total Value
$5.78K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,681
Price
$28.44
Total Value
$332.21K
Shares Held After
378,002
% of Holdings
3.0%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Mahboob Vaseem — Chief Financial Officer
Shares
39,903
Price
$30.48
Total Value
$1.22M
Shares Held After
60,609
% of Holdings
39.7%
DANAHER CORP /DE/ (DHR)
Bouda Christopher — VP, Chief Accounting Officer
Shares
3,253
Price
$234.58
Total Value
$763.09K
Shares Held After
9,107
% of Holdings
26.3%
DANAHER CORP /DE/ (DHR)
Bouda Christopher — VP, Chief Accounting Officer
Shares
4,345
Price
$234.54
Total Value
$1.02M
Shares Held After
9,107
% of Holdings
32.3%
DANAHER CORP /DE/ (DHR)
McGrew Matthew — Executive Vice President
Shares
15,603
Price
$236.09
Total Value
$3.68M
Shares Held After
12,674
% of Holdings
55.2%
DANAHER CORP /DE/ (DHR)
McGrew Matthew — Executive Vice President
Shares
14,151
Price
$235.35
Total Value
$3.33M
Shares Held After
12,674
% of Holdings
52.8%
5189 transactions